Qiagen and Clinical Genomics announced a partnership to use the PAXGene Blood ccfDNA Tube for collection and handling of blood samples in Clinical Genomics' Colvera colorectal cancer recurrence assay workflow. The PAXGene Blood ccfDNA system was developed by PreAnalytix, a Qiagen/Becton Dickinson joint venture. Colvera is a PCR-based assay that detects hypermethylated BCAT1 and IKZF1 DNA in the blood of patients.

Registering provides access to this and other free content.

Already have an account?.

Go here to see the original:
In Brief This Week: Qiagen, Clinical Genomics, Streck, Oxford Genetics, Isohelix - GenomeWeb